Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis - PubMed (original) (raw)
doi: 10.1002/hep.510300211.
T Suda, Y Aoyagi, H Kawai, T Yokota, T Takahashi, K Tsukada, T Shimizu, S Mori, Y Abe, Y Suzuki, M Nomoto, Y Mita, M Yanagi, H Igarashi, H Asakura
Affiliations
- PMID: 10421648
- DOI: 10.1002/hep.510300211
Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis
O Isokawa et al. Hepatology. 1999 Aug.
Abstract
Hepatocellular carcinoma (HCC) mainly arises from the liver with chronic inflammation. Because telomere reduction reflects replicative history in somatic cells, we analyzed the possibility that liver tissues surrounding HCC consist of the cells carrying substantial reduction of telomere. We studied 20 HCC and surrounding noncancerous liver tissues (SL) obtained by surgical resection, and 10 laparoscopically obtained needle biopsy specimens of the liver with chronic inflammation including no overt HCC (CI). Five liver tissues without chronic liver diseases (ND) were also examined. Extracted genomic DNAs were blotted on a nylon membrane, and probed at first with radio-labeled d(TTAGGG)(3) and reprobed with radio-labeled d(CCT)(7). The intensity caused by d(TTAGGG)(3) was divided by that of d(CCT)(7). The ratio was defined as telomeric repeats content (TC). Dilution experiments reproducibly revealed almost the same TC. The reduction rate of telomere length through aging estimated by regression analysis of TC was 0.62% per year. Concomitant analyses of TC and average telomere length revealed that both values were significantly correlated (r =.45; P =.009). To compare TC in the liver with respect to chronic inflammation, the value was divided by TC in peripheral blood leukocytes (PBL) from the same donor. The ratio was defined as relative TC (RTC). There was a statistically significant decrease of RTC in CI compared with that in ND (P =.03). Furthermore, RTC in SL was significantly lower than that in CI (P =.0001). These observations suggest that RTC value in liver tissues may digitally indicate a replicative history of hepatocytes under chronic inflammation, and a risk of HCC development.
Similar articles
- Interferon can block telomere erosion and in rare cases result in hepatocellular carcinoma development with telomeric repeat binding factor 1 overexpression in chronic hepatitis C.
Igarashi M, Suda T, Hara H, Takimoto M, Nomoto M, Takahashi T, Okoshi S, Kawai H, Mita Y, Waguri N, Aoyagi Y. Igarashi M, et al. Clin Cancer Res. 2003 Nov 1;9(14):5264-70. Clin Cancer Res. 2003. PMID: 14614008 - Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.
Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka S, Manns MP, Rudolph KL. Plentz RR, et al. Hepatology. 2004 Jul;40(1):80-6. doi: 10.1002/hep.20271. Hepatology. 2004. PMID: 15239089 - Telomere length variation and maintenance in hepatocarcinogenesis.
Yokota T, Suda T, Igarashi M, Kuroiwa T, Waguri N, Kawai H, Mita Y, Aoyagi Y. Yokota T, et al. Cancer. 2003 Jul 1;98(1):110-8. doi: 10.1002/cncr.11428. Cancer. 2003. PMID: 12833463 - The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F, Vangieri B, Cecere A, Gattoni A. Marotta F, et al. Clin Ter. 2004 May;155(5):187-99. Clin Ter. 2004. PMID: 15344567 Review. - Molecular pathogenesis of hepatocellular carcinoma.
McKillop IH, Moran DM, Jin X, Koniaris LG. McKillop IH, et al. J Surg Res. 2006 Nov;136(1):125-35. doi: 10.1016/j.jss.2006.04.013. Epub 2006 Oct 3. J Surg Res. 2006. PMID: 17023002 Review.
Cited by
- Inflammasomes in Inflammation-Induced Cancer.
Lin C, Zhang J. Lin C, et al. Front Immunol. 2017 Mar 15;8:271. doi: 10.3389/fimmu.2017.00271. eCollection 2017. Front Immunol. 2017. PMID: 28360909 Free PMC article. Review. - Associations between polymorphisms of the ACYP2 gene and Liver cancer risk: A case-control study and meta-analysis.
Zhao W, Liu X, Yu Z, Xiong Z, Wu J, Sun Y, Niu F, Liu J, Jin T. Zhao W, et al. Mol Genet Genomic Med. 2019 Jul;7(7):e00716. doi: 10.1002/mgg3.716. Epub 2019 May 23. Mol Genet Genomic Med. 2019. PMID: 31124313 Free PMC article. - Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC).
Misceo D, Mocciaro G, D'Amore S, Vacca M. Misceo D, et al. Nutr Metab (Lond). 2024 Dec 23;21(1):112. doi: 10.1186/s12986-024-00871-3. Nutr Metab (Lond). 2024. PMID: 39716321 Free PMC article. Review. - Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma.
Miki D, Aikata H, Uka K, Saneto H, Kawaoka T, Azakami T, Takaki S, Jeong SC, Imamura M, Kawakami Y, Takahashi S, Itamoto T, Asahara T, Arihiro K, Chayama K. Miki D, et al. J Gastroenterol. 2008;43(7):550-7. doi: 10.1007/s00535-008-2194-5. Epub 2008 Jul 23. J Gastroenterol. 2008. PMID: 18648742 - Treatment for hepatocellular carcinoma in elderly patients: a literature review.
Nishikawa H, Kimura T, Kita R, Osaki Y. Nishikawa H, et al. J Cancer. 2013 Sep 14;4(8):635-43. doi: 10.7150/jca.7279. J Cancer. 2013. PMID: 24155775 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical